Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models. [electronic resource]
Producer: 20171122Description: 157-169 p. digitalISSN:- 2326-6074
- Animals
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Dasatinib -- pharmacology
- Disease Models, Animal
- Female
- Humans
- Immunomodulation -- drug effects
- Killer Cells, Natural -- drug effects
- Lymphocyte Activation -- drug effects
- Lymphocytes, Tumor-Infiltrating -- drug effects
- Melanoma, Experimental
- Mice
- Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- pharmacology
- T-Lymphocyte Subsets -- drug effects
- Tumor Burden -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.